Wordt geladen...
Therapeutic targeting of BRCA1-mutated breast cancers with agents that activate DNA repair
Cancers due to germline mutations in the BRCA1 gene tend to lack targets for approved chemoprevention agents. This study aimed at a targeted chemoprevention strategy for BRCA1-associated malignancies. Mutant BRCA1 limits the base-excision DNA repair activity that addresses oxidative DNA damage, the...
Bewaard in:
| Gepubliceerd in: | Cancer Res |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4388430/ https://ncbi.nlm.nih.gov/pubmed/25217519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-1716 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|